Dr. Mark W. Knestrick
Overview
Mark Knestrick, MD, Pharm.D., is a medical oncologist and hematologist.Dr. Knestrick is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from West Virginia University in Morgantown and his pharmacy degree from Duquesne University in Pittsburgh. Dr. Knestrick completed both a residency in internal medicine and a hematology/oncology fellowship at West Virginia University Department of Medicine. Dr. Knestrick is a member of the American Medical Association and American Society of Clinical Oncology.
Dr. Knestrick is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Malignant Mixed Mullerian Tumor, Childhood Iron Deficiency Anemia, Lung Cancer, and Pleuropulmonary Blastoma.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3204 Johnson Road, Steubenville, OH 43952
470 Johnson Road, Suite 10, Washington, PA 15301
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of Pittsburgh Physicians
Jason Luke is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Luke is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
UPMC Hillman Cancer Center
John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.
UPMC Hillman Cancer Center
Yana G. Najjar, MD is a translational investigator and cutaneous oncologist at UPMC Hillman Cancer Center, where she also is an associate professor of medicine and Director of the Clinical and Translational Research Center. Dr. Najjar specializes in early phase clinical trials and in the treatment of advanced melanoma. Her research focusing on immunotherapy resistant melanoma and rare melanoma subtypes. She has developed multiple investigator-initiated trials that aim to remodel melanoma tumor cell metabolism and hypoxia in the tumor microenvironment to overcome mechanisms of resistance to immunotherapy. Her lab is focused on various correlative analyses from investigator-initiated trials. Dr. Najjar's research is funded by the NIH, the Department of Defense, and the Melanoma Research Alliance. Dr. Najjar is rated as a Distinguished provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC), and Gamma Knife Radiosurgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Mountain SicknessDr. Knestrick isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung CancerDr. Knestrick isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AngiosarcomaDr. Knestrick isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Knestrick isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Knestrick isAdvanced. Learn about Breast Cancer in Men.
- Childhood Iron Deficiency AnemiaDr. Knestrick isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Experienced
- Acute Eosinophilic PneumoniaDr. Knestrick isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Knestrick isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Knestrick isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Knestrick isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaDr. Knestrick isExperienced. Learn about Adult T-Cell Leukemia.